Sponsor Deadline
Posted: 6/30/2025

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Note: This is a Forecasted Opportunity.

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the NIAID Clinical Trial Implementation Cooperative Agreements. This program encourages cooperative agreement applications for implementation of investigator-initiated, milestone driven, high-risk clinical trials including mechanistic studies associated with these clinical trials. Due to this focus, the program encompasses both basic and clinical research. This program includes support for the conduct, completion, and analysis of the clinical trial. Additional activities supported are related to the conduct of the clinical trial including training of study personnel; enrollment and recruitment of study subjects; data collection, clinical data management and quality control; investigational product costs; laboratory work and data analyses; study management and oversight; post-trial activities; and regulatory activities and site monitoring. 

 

Estimated Post Date:

Dec 05, 2025

Estimated Application Due Date:

Feb 25, 2026

Funding Type
Eligibility
Posted
6/30/2025
Deadline
Sponsor: